South Africa

This archive collects solutions-journalism stories and progress milestones from South Africa, spanning health, environment, education, and civic life. Each entry highlights real developments — policies enacted, communities organized, problems solved — reported without hype.

A Cape leopard moving through natural scrubland for an article about Cape leopard return to West Coast National Park

Cape leopard photographed in South Africa’s West Coast National Park after 170-year absence

By / / Good News For Humankind

Cape leopard return to West Coast National Park marks the first confirmed sighting in roughly 170 years, after the species was hunted to local extinction during the colonial era. A remote camera trap caught the animal inside the park, and SANParks confirmed it arrived naturally, migrating through agricultural corridors connecting the Cederberg mountains to the coast. No reintroduction was involved. The sighting reflects decades of quiet conservation work — reduced snaring, habitat restoration, and landowner cooperation — that stitched together a functional movement corridor. When an apex predator walks back on its own, it means the landscape is finally healthy enough to hold it.

A farmworker walks through a maize field at dawn for an article about the South Africa terbufos ban — 13 words.

South Africa bans terbufos pesticide, protecting farming communities

By / / Good News For Humankind

Terbufos ban marks a major win for South Africa’s farmworker communities, as the country moves to prohibit one of the world’s most hazardous pesticides starting in 2026. The organophosphate chemical, rated “extremely hazardous” by the World Health Organization, had been routinely applied to maize and sugarcane while exposing rural workers and children to potentially fatal risks. The ban followed a multi-year campaign by the Center for Environmental Rights and the Rural Women’s Assembly, combining toxicological evidence with direct community testimony. South Africa joins the EU and other nations in phasing out terbufos, signaling that grassroots advocacy centered on vulnerable communities can reshape national chemical policy.

Virus up close, for article on lenacapavir HIV prevention

‘Gamechanger’ HIV prevention drug to be made available cheaply in 120 countries

By / / Good News For Humankind

Lenacapavir, a twice-yearly HIV prevention shot with near-perfect results in clinical trials, is about to become far more affordable for millions of people. Gilead Sciences has licensed six generic manufacturers across India, Egypt, Pakistan, and the U.S. to produce the drug for 120 lower-income countries, where researchers estimate it could eventually be made for as little as $40 per patient per year. In trials among cisgender women in South Africa and Uganda, not a single participant who received the injection contracted HIV. Advocates are urging wider access, since much of Latin America was left out of the deal. Still, it’s a hopeful signal that breakthrough prevention tools can reach the people who need them most — fast.

South African flag, for article on South Africa Climate Change Act

South Africa passes its first sweeping climate change law

By / / Good News For Humankind

South Africa’s new Climate Change Act, signed by President Cyril Ramaphosa in July 2024, gives the country its first legally binding framework for cutting emissions and adapting to a warming world. For a nation that generates roughly 40% of sub-Saharan Africa’s carbon emissions, that legal spine matters enormously. The law creates enforceable carbon budgets, requires government departments to report progress every five years, and writes just transition principles directly into the text, recognizing coal workers and their communities as the energy system shifts. Advocates spent years pushing for this across multiple administrations. It’s a foundation rather than a finish line, but a foundation that can be built upon, challenged in court, and strengthened in ways voluntary pledges never allowed.

Good news for public health, for article on CAB-LA HIV prevention, for article on lenacapavir HIV prevention, for article on HIV infections in young men

New twice-yearly shot to prevent HIV achieves 100% success rate in late-stage trial

By / / Good News For Humankind

Lenacapavir, a twice-yearly HIV prevention shot, protected every single one of 2,134 women who received it in a late-stage trial across South Africa and Uganda — a 100% efficacy result so striking that monitors ended the blinded phase early. The breakthrough matters because daily prevention pills, while powerful in theory, often falter in real life: stigma, forgotten doses, and disrupted routines all chip away at protection. Two clinic visits a year, by contrast, means a full year of coverage. The remaining hurdle is access, with advocates pressing manufacturer Gilead to license generic versions for the regions hardest hit. If that happens, a tool this effective could reshape the global push to end the HIV epidemic by 2030.

Rhinos, for article on white rhino rewilding

Africa NGO purchases world’s largest captive rhino population to rewild 2,000 across the continent

By / / Good News For Humankind

More than 2,000 white rhinos — roughly 15% of the wild southern white rhino population — are heading back to the wild, thanks to a landmark purchase by African Parks. The conservation NGO bought the entire Platinum Rhino herd and plans to release the animals across protected sites in southern Africa over the next decade. The rhinos lived in semi-wild conditions on the ranch, and experts believe they’ll adapt quickly to true wilderness, drawing on African Parks’ experience relocating thousands of animals across the continent. If it succeeds, this rewilding effort could become a defining chapter in one of conservation’s greatest comeback stories — and a hopeful blueprint for protecting threatened species worldwide.